Kanna Health
John Boghossian is currently the CEO and co-founder of Kanna Health and co-founder of Pangea Bio. Prior to this role, John served as the CEO and Board member of Quercis Pharma and held various positions at COMPASS Pathways. With a background in engineering and economics, John pursued further education with an MBA from Harvard Business School. Throughout their career, John has also gained experience through internships at IBM Corporation, Credit-Suisse Group, Enel, and Oliver Wyman Financial Services.
This person is not in any teams
This person is not in any offices
Kanna Health
We are a clinical stage company developing novel therapeutics inspired by kanna, or Sceletium tortuosum. Kanna is a medicinal succulent traditionally used by the San hunter-gatherers of South Africa.